Chris Eijsbouts is Chief Science Officer at Mable with a PhD in Genomic Medicine from the University of Oxford and a Masters in Computational Biology.
Education
PhD in Genomic Medicine from the University of Oxford
Masters in Computational Biology from the University of Cambridge
Certifications
Chris Eijsbouts has a PhD in Genomic Medicine from the University of Oxford and a Masters in Computational Biology from the University of Cambridge. He has previously published his research in renowned journals such as Nature Genetics and is responsible for genomic data analysis at Mable.
About our medical review process
At Mable, we are committed to providing every individual with clear, credible, evidence-based health and wellness information. To be your most trusted source of information, our content is medically reviewed to verify the clinical accuracy of our content, images, products, and services. Medical review is provided by members of our team. Our team brings an extensive experience from across the spectrum of medical specialties, as well as their perspective from years of clinical practice, research, and patient advocacy.